UTMD:NASDAQUtah Medical Products, Inc. Analysis

Utah Medical Products is trading firmly above its short‑term moving averages, with the 20‑day SMA comfortably higher than the 50‑day and 200‑day levels, indicating a sustained bullish bias. The MACD histogram remains positive and the signal line points upward, while the RSI sits in a neutral zone, suggesting limited upside momentum but no immediate overbought risk. Technical momentum is reinforced by increasing volume, a clear support zone just below the current price, and a resistance ceiling that remains intact.
On the fundamentals side, the company boasts a PE multiple that sits well below the industry average, a modest dividend yield supported by a low payout ratio, and a balance sheet awash in cash with negligible debt. However, revenue has been contracting, and operating cash flow appears flat, which tempers enthusiasm despite strong gross and operating margins. Recent quarterly filings highlighted continued top‑line decline, underscoring the need for a turnaround in sales while the dividend and cash cushion provide a degree of defensive stability.